is a software company that licenses and sells software designed for:
Tailored Individual Prognosis
Individually Tailored Cure Analysis
All solutions are tailored to progressive human diseases.
also provides software for Market Research:
Experimental Market Analysis
Dr. James R. Miller III
16641 West Loma Verde Trail
Surprise, AZ 85387
Recent applications and publications regarding MDMS proprietary software:
Proceedings of the National Academy of Sciences - "
A multi-marker assay to distinguish malignant melanomas from benign nevi
Public Library of Science (PLOS) - "
A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer
Recent publications available at the
Patient-Centered Cure Assessment
A Methodology to Assess Whether Medical Interventions Succeed in Curing Individual Patients
Methodologies to Predict Individually Tailored Outcomes of Current Diagnostic Tests and to Create New Tests
A Methodology to Improve Individually Tailored Prognostic Accuracy Illustrated in Two Cancers